Team:Yale
From 2014.igem.org
(Difference between revisions)
Line 35: | Line 35: | ||
<tr> | <tr> | ||
<td style="border:none;" colspan="3" align="center" height="150px"> | <td style="border:none;" colspan="3" align="center" height="150px"> | ||
- | <h1 style="display:none">Biosynthesis of an Anti-biofouling Surface Binding Polymer with the 21st Amino Acid- L- | + | <h1 style="display:none">Biosynthesis of an Anti-biofouling Surface Binding Polymer with the 21st Amino Acid- L-DOPA</h1> |
<br> | <br> | ||
<p> <img src="https://static.igem.org/mediawiki/2014/c/c1/IGEMLogoFinalYale2014.png" > </p> | <p> <img src="https://static.igem.org/mediawiki/2014/c/c1/IGEMLogoFinalYale2014.png" > </p> | ||
Line 42: | Line 42: | ||
<!-- end welcome box --> | <!-- end welcome box --> | ||
<tr><td colspan="3"><div class = "well" ><p> <strong><center>Producing a Novel Antimicrobial Surface-Binding Peptide Using an Improved T7 Expression System</center></strong><p> | <tr><td colspan="3"><div class = "well" ><p> <strong><center>Producing a Novel Antimicrobial Surface-Binding Peptide Using an Improved T7 Expression System</center></strong><p> | ||
- | Biofilm formation on surfaces is an issue in the medical field, naval industry, and other areas. We developed an anti-fouling peptide with two modular components: a mussel adhesion protein (MAP) anchor and LL-37, an antimicrobial peptide. MAPs can selectively attach to metal and organic surfaces via L- | + | Biofilm formation on surfaces is an issue in the medical field, naval industry, and other areas. We developed an anti-fouling peptide with two modular components: a mussel adhesion protein (MAP) anchor and LL-37, an antimicrobial peptide. MAPs can selectively attach to metal and organic surfaces via L-3,5-dihydroxyphenylalanine (L-DOPA), a nonstandard amino acid that was incorporated using a genetically recoded organism (GRO). Because this peptide is toxic to the GRO in which it is produced, we designed a better controlled inducible system that limits basal expression. This was achieved through a novel T7 riboregulation system that controls expression at both the transcriptional and translational levels. This improved system is a precise synthetic switch for the expression of cytotoxic substances in the already robust T7 system. Lastly, the antimicrobial surface-binding peptide was assayed for functionality. |
</p></div></td> | </p></div></td> | ||
</tr> | </tr> |
Revision as of 00:10, 18 October 2014